Sanofi-Aventis Names Chief Science Officer

Drug developer Sanofi-Aventis SA said Monday it named Dr. Paul Chew to the newly created position of chief science officer-chief medical officer, effective April 1.

NEW YORK (AP) -- Drug developer Sanofi-Aventis SA said Monday it named Dr. Paul Chew to the newly created position of chief science officer-chief medical officer, effective April 1.

He was previously president of research and development at the Paris-based company. Under the new position, he will oversee medical affairs in addition to continued oversight of research and development.

Shares of Sanofi-Aventis rose 67 cents, or 2.6 percent, to $26.97 in afternoon trading. The stock has traded between $23.95 and $39.70 over the past 52 weeks.

 

More in Home